A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

ClinicalTrials.gov ID: NCT07293351

Public ClinicalTrials.gov record NCT07293351. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 3, 2026, 6:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ROSETTA RCC-208: A Phase 1/2 Open-label, Multi-center, Randomized Study of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety, tolerability, and efficacy of Pumitamig alone or in combination with other agents in participants with advanced Renal Cell Carcinoma (RCC)

Study identification

NCT ID: NCT07293351
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: Bristol-Myers Squibb; Industry
Enrollment: 474 participants

Conditions and interventions

Conditions

Advanced Renal Cell Carcinoma (RCC)

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 25, 2026
Primary completion: Nov 27, 2029
Completion: Nov 25, 2031
Last update posted: Aug 27, 2026

2026 – 2031

United States locations

U.S. sites: 18
U.S. states: 15
U.S. cities: 18

Facility	City	State	ZIP	Site status
Local Institution - 0178	Palo Alto	California	94305	Not yet recruiting
Local Institution - 0117	New Haven	Connecticut	06510	Not yet recruiting
Sibley Memorial Hospital	Washington D.C.	District of Columbia	20016	Recruiting
Local Institution - 0177	Miami	Florida	33136	Not yet recruiting
Local Institution - 0126	Orlando	Florida	32803	Not yet recruiting
Local Institution - 0175	Atlanta	Georgia	30322	Not yet recruiting
Local Institution - 0170	Fort Wayne	Indiana	46825	Not yet recruiting
University Of Iowa Hospitals And Clinics	Iowa City	Iowa	52242	Recruiting
Johns Hopkins Hospital	Baltimore	Maryland	21287	Recruiting
Local Institution - 0176	Big Rapids	Michigan	49307	Not yet recruiting
Washington University School of Medicine	St Louis	Missouri	63110	Recruiting
Memorial Sloan Kettering Cancer Center	Hauppauge	New York	11788	Recruiting
Local Institution - 0135	Cincinnati	Ohio	45219	Not yet recruiting
Cleveland Clinic	Cleveland	Ohio	44195	Recruiting
MUSC Hollings Cancer Center	Charleston	South Carolina	29425	Recruiting
Carolina Urologic Research Center, LLC	Myrtle Beach	South Carolina	29572	Recruiting
Local Institution - 0158	Salt Lake City	Utah	84112	Withdrawn
Local Institution - 0095	Seattle	Washington	98109-1023	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 74 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07293351, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 27, 2026 · Synced Sep 3, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07293351 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →